TY - JOUR
T1 - Low-dose intestinal Trichuris muris infection alters the lung immune microenvironment and can suppress allergic airway inflammation
AU - Chenery, Alistair L.
AU - Antignano, Frann
AU - Burrows, Kyle
AU - Scheer, Sebastian
AU - Perona-Wright, Georgia
AU - Zaph, Colby
PY - 2016
Y1 - 2016
N2 - Immunological cross talk between mucosal tissues such as the intestine and the lung is poorly defined during homeostasis and disease. Here, we show that a low-dose infection with the intestinally restricted helminth parasite Trichuris muris results in the production of Th1 cell-dependent gamma interferon (IFN-γ) and myeloid cell-derived interleukin-10 (IL-10) in the lung without causing overt airway pathology. This cross-mucosal immune response in the lung inhibits the development of papain-induced allergic airway inflammation, an innate cell-mediated type 2 airway inflammatory disease. Thus, we identify convergent and nonredundant roles of adaptive and innate immunity in mediating cross-mucosal suppression of type 2 airway inflammation during low-dose helminth-induced intestinal inflammation. These results provide further insight in identifying novel intersecting immune pathways elicited by gut-to-lung mucosal cross talk.
AB - Immunological cross talk between mucosal tissues such as the intestine and the lung is poorly defined during homeostasis and disease. Here, we show that a low-dose infection with the intestinally restricted helminth parasite Trichuris muris results in the production of Th1 cell-dependent gamma interferon (IFN-γ) and myeloid cell-derived interleukin-10 (IL-10) in the lung without causing overt airway pathology. This cross-mucosal immune response in the lung inhibits the development of papain-induced allergic airway inflammation, an innate cell-mediated type 2 airway inflammatory disease. Thus, we identify convergent and nonredundant roles of adaptive and innate immunity in mediating cross-mucosal suppression of type 2 airway inflammation during low-dose helminth-induced intestinal inflammation. These results provide further insight in identifying novel intersecting immune pathways elicited by gut-to-lung mucosal cross talk.
UR - http://www.scopus.com/inward/record.url?scp=84957612502&partnerID=8YFLogxK
U2 - 10.1128/IAI.01240-15
DO - 10.1128/IAI.01240-15
M3 - Article
C2 - 26644379
AN - SCOPUS:84957612502
SN - 0019-9567
VL - 84
SP - 491
EP - 501
JO - Infection and Immunity
JF - Infection and Immunity
IS - 2
ER -